Legal
AliExpress Fined $625M Over Unsafe Toys, Cosmetics
The EU's largest Digital Services Act fine yet accuses AliExpress of giving moderators mere seconds to catch banned toys and cosmetics.
Latest — Page 7
FDA
Kyverna's NIH-licensed CAR T nears first autoimmune nod
Kyverna licensed its CAR T from the NIH in 2022 before autoimmune data existed. The FDA just agreed a single-arm trial is enough to file.
Legal
Orders French ISPs to Block Polymarket
France ordered its internet providers to cut off Polymarket, citing hacked weather sensors and zero identity checks on French bettors.
Legal
Treasury Opens GOLD EAGLE Under EO 14409
Treasury's new GOLD EAGLE clearinghouse is voluntary on paper. Examiners have a way of turning voluntary data sources into checklist items.
FDA
Novartis Locks Full FDA Nod for Fabhalta in Kidney Disease
Novartis turned a surrogate-endpoint approval into a full one, and it's already the third kidney drug in its IgAN lineup, cementing its market lead.
FDA
Boosts $6B case for Insmed's TPIP
Guggenheim floats a $6 billion peak for Insmed's inhaled PAH drug, but Truist says the dosing data doesn't back the differentiator yet.
Deals
BlossomHill Files for IPO to Chase AstraZeneca
BlossomHill is asking public markets for $100M to challenge AstraZeneca's $7.25B-a-year Tagrisso, backed by nothing past phase 1/2 data.
Deals
Bought Comerica for $10.9B, Fifth Third Nears $850M Win
Comerica's board took a 20% premium in October. Now Fifth Third's $850 million synergy bet gets tested over the Labor Day weekend conversion.
FDA
Forces PBMs to Prove Every Rebate in 30 Months
Spreadsheets won't cut it anymore: PBMs must now prove, claim by claim, how every rebate and price spread was calculated under the 30-month deadline.
Deals
Lakestar Closes $300M Resilience Fund for EU Defense
Lakestar closed a $300 million fund betting Brussels' sovereignty anxiety turns into procurement revenue for Helsing and Auterion.
Legal
Coca-Cola's Fairlife Halts Output in 17th US Breach of 2026
Coca-Cola's Fairlife brand just became the 17th US cyberattack of 2026, and the SEC's four-day disclosure clock is already running.
FDA
GSK Drops $2B Cough Drug After Trial Split
GSK just wrote off a chunk of its $2B Bellus buy, admitting camlipixant "is unlikely to transform patient care" after a split Phase 3 readout.
AI
SF Orders Apple, Google to Pull 13 Nudify Apps
San Francisco's city attorney's office estimates Apple and Google made millions hosting apps that fake-strip real photos. He's demanding all 13 come down.
Legal
20 AGs Ask OCC to Block OppFi's $130M Bank Buy
20 state AGs told the OCC, FDIC and Fed to kill OppFi's and Enova's bank buys, calling the deals a blueprint for evading rate caps.
AI
Orders 4-Year Paper Trail on AI Hiring Screens
Stanford found AI hiring bots cost 40,000 qualified Black and Asian applicants a shot, and California just made ignoring that a legal liability.
